1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. PDGFR
  4. PDGFR Inhibitors

PDGFR Inhibitors

PDGFR

PDGFRβ

PDGFRα

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PDGFR Inhibitors
Product Name PDGFR PDGFRβ PDGFRα Purity
Lenvatinib  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.74%
Nintedanib  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.97%
Regorafenib  
PDGFRβ, IC50: 22 nM
  99.96%
Ponatinib    
PDGFRα, IC50: 1.1 nM
99.13%
Sunitinib  
PDGFRβ, IC50: 2 nM
  99.66%
Tandutinib hydrochloride
PDGFR, IC50: 0.2 μM
    98.84%
SU16f
PDGFR2, IC50: 140 nM
PDGFR1, IC50: 2.29 μM
PDGFRβ, IC50: 10 nM
  >99.0%
Axitinib  
PDGFRβ, IC50: 1.6 nM
  99.94%
Crenolanib  
PDGFRβ, Kd: 3.2 nM
PDGFRα, Kd: 2.1 nM
99.67%
SU 5402  
PDGFRβ, IC50: 510 nM
  99.39%
Cediranib  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
99.58%
CP-673451  
PDGFRβ, IC50: 1 nM
PDGFRα, IC50: 10 nM
99.65%
Ripretinib    
PDGFRA
99.46%
Sunitinib Malate  
PDGFRβ, IC50: 2 nM
  99.47%
Nintedanib esylate  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.95%
Linifanib  
PDGFRβ, IC50: 66 nM
  99.60%
Dovitinib  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
97.18%
CHIR-124
PDGFR, IC50: 6.6 nM
    98.07%
SU14813  
PDGFRβ, IC50: 4 nM
  98.90%
Regorafenib Hydrochloride  
PDGFRβ, IC50: 22 nM
  99.58%
Pazopanib Hydrochloride  
PDGFRβ, IC50: 84 nM
  99.83%
Amuvatinib    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
99.36%
ENMD-2076    
PDGFRα, IC50: 56.4 nM
99.23%
Regorafenib monohydrate  
PDGFRβ, IC50: 22 nM
  99.96%
Telatinib    
PDGFRα, IC50: 15 nM
99.49%
PP121
PDGFR, IC50: 2 nM
    98.89%
Toceranib phosphate  
PDGFRβ, Ki: 5 nM
  98.43%
TAK-593  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 4.3 nM
PDGFRαV561D, IC50: 1 nM
99.62%
Tandutinib
PDGFR, IC50: 0.2 μM
    99.48%
ENMD-2076 Tartrate    
PDGFRα, IC50: 56.4 nM
98.59%
PP58
PDGFR
   
Toceranib  
PDGFRβ, Ki: 5 nM
  96.25%
SU14813 maleate  
PDGFRβ, IC50: 4 nM
  99.95%
Orantinib  
PDGFRβ, Ki: 8 nM
  98.80%
Cediranib maleate  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
96.67%
Ilorasertib hydrochloride  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
98.91%
AC710  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM
98.03%
JI-101  
PDGFRβ
  99.95%
NVP-ACC789  
PDGFR-β, IC50: 1.4 μM
  99.58%
AZD2932  
PDGFRβ, IC50: 4 nM
  98.12%
PDGFRα kinase inhibitor 1  
PDGFRβ, IC50: 6115 nM
PDGFRα, IC50: 132 nM
99.90%
JNJ-​10198409  
PDGFRβ, IC50: 4.2 nM
PDGFRα, IC50: 45 nM
>99.0%
Tyrosine kinase-IN-1    
PDGFRα, IC50: 4 nM
99.47%
Ilorasertib  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
Lenvatinib mesylate  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
GZD856  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
Telatinib mesylate    
PDGFRα, IC50: 15 nM
Amuvatinib hydrochloride    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
Tyrphostin AG1433  
PDGFRβ, IC50: 5 μM
  99.20%
Methylnissolin
PDGFR, IC50: 10 μM
   
Sunitinib D10  
PDGFRβ, IC50: 2 nM
 
Ponatinib D8    
PDGFRα, IC50: 1.1 nM
SKLB610
PDGFR
    99.23%
AC710 Mesylate  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM